- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01643798
Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia
Study Overview
Detailed Description
Non-invasive forms of brain stimulation such as transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS) are currently being investigated as alternative or adjunctive therapies for pain. Clinical interest in these techniques continues to grow because of rising opiate abuse and inadequate pain management strategies. Despite this enthusiasm, studies on the efficacy of repetitive TMS (rTMS) for pain have produced mixed results. Some of the most promising and informative research has focused on rTMS for perioperative pain. In two different postoperative studies, a single session of left dorsolateral prefrontal cortex (DLPFC) rTMS after gastric bypass surgery reduced morphine self-administration by 40% when compared to sham stimulation. These data are particularly fascinating given the role of the DLPFC in top-down pain processing.
Centered at the juncture of Brodmann Areas (BAs) 9 and 46, the DLPFC remains a popular therapeutic target for rTMS given its accessible location and presumed role in high-order cognition and emotional valence. Animal and human studies suggest that cingulofrontal regions like DLPFC may modulate pain perception via recruitment of opioidergic midbrain and brainstem structures like the periaqueductal gray (PAG) and the rostroventromedial medulla (RVM), respectively. These data outline the functional circuitry that might be involved in the analgesic effects of DLPFC rTMS.
While many studies aim to evaluate the clinical efficacy of DLPFC rTMS for pain management, few have examined how it affects pain processing. Imaging the cerebral signature of pain before and after left DLPFC rTMS might reveal information about pain circuitry and help to elucidate the mechanism by which prefrontal rTMS may produce analgesia. Previous studies suggest that opioid blockade abolishes left but not right DLPFC rTMS-induced analgesia. In this study, our a priori hypothesis was that left DLPFC rTMS would attenuate blood oxygenation-level dependent (BOLD) signal response to painful stimuli in pain processing regions. More specifically, we anticipated that midbrain and medulla BOLD signal changes induced by left DLPFC rTMS would be abolished by pretreatment with the μ-opioid antagonist naloxone.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29414
- Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy volunteers
- no history of depression or pain
- no metal in body
- no medications that lower seizure threshold
Exclusion Criteria:
- history of depression or pain
- history of seizures or epilepsy
- metal implants in body
- medications that lower seizure threshold
- psychiatric medications
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Saline
Participants received intravenous saline immediately prior to sham and real rTMS of the left dorsolateral prefrontal cortex.
The parameters of the stimulation paradigm are as follows: 10 Hz, 5 seconds on, 10 seconds off, 20 minutes, 4000 pulses).
|
The eSham system was implemented in conjunction with a specialized Neuronetics sham TMS coil.
This coil has a metal plate hidden inside of it that blocks the magnetic field from affecting the brain.
Scalp electrodes were used to mimic the feel of real rTMS.
This approach has been validated in previous studies.
Other Names:
An iron-core, solid-state figure-of-8 coil was used to stimulate the dorsolateral prefrontal cortex.
The site of stimulation was estimated using the Beam F3 method based on the 10-20 EEG system.
Other Names:
|
Active Comparator: Naloxone
Participants received intravenous naloxone (0.1mg/kg) immediately prior to sham and real rTMS of the left dorsolateral prefrontal cortex.
The parameters of the stimulation paradigm are as follows: 10 Hz, 5 seconds on, 10 seconds off, 20 minutes, 4000 pulses).
|
The eSham system was implemented in conjunction with a specialized Neuronetics sham TMS coil.
This coil has a metal plate hidden inside of it that blocks the magnetic field from affecting the brain.
Scalp electrodes were used to mimic the feel of real rTMS.
This approach has been validated in previous studies.
Other Names:
An iron-core, solid-state figure-of-8 coil was used to stimulate the dorsolateral prefrontal cortex.
The site of stimulation was estimated using the Beam F3 method based on the 10-20 EEG system.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Rating
Time Frame: Baseline (60 minutes into experiment), Post-Sham (90 minutes), Post-Real (120 minutes)
|
There are two experimental visits separated by one week.
During each experiment, pain ratings will be measured every 30 minutes.
"Preliminary testing" will be done 30 minutes into the experiment.
The purpose of preliminary testing is to select the temperature that will be used to induce pain throughout the experiment.
"Baseline testing" will be done 60 minutes into the experiment.
"After sham rTMS" will be done 90 minutes into the experiment.
"After real rTMS" will be done 120 minutes into the study.
The pain scale used in a Visual Analog Scale (VAS).
There was an 11-point rating system where "0" represented no pain and "10" represented unbearable pain.
|
Baseline (60 minutes into experiment), Post-Sham (90 minutes), Post-Real (120 minutes)
|
Change in BOLD Signal in Pain Processing Regions During Pain, Including Supraspinal Opioidergic Structures
Time Frame: Baseline (60 minutes into experiment), Post-Sham (90 minutes), Post-Real (120 minutes)
|
There are two experimental visits separated by one week.
During each experiment, blood oxygen level dependent (BOLD) signal will be measured at baseline (60 minutes into the experiment), post-sham rTMS (90 minutes into the experiment) and post-real (120 minutes into the experiment).
|
Baseline (60 minutes into experiment), Post-Sham (90 minutes), Post-Real (120 minutes)
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Joseph J Taylor, Medical University of South Carolina
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1F30DA033748 (U.S. NIH Grant/Contract)
- 1F30DA033748-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
Clinical Trials on Sham rTMS
-
Chang Gung Memorial HospitalRecruiting
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Bayside HealthCompletedAutistic Disorder | Asperger's DisorderAustralia
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanRecruiting
-
Duke UniversityNational Institute on Aging (NIA)Completed
-
Butler HospitalCompletedObsessive-Compulsive DisorderUnited States
-
VA Office of Research and DevelopmentCompleted
-
Centre Hospitalier EsquirolCompleted
-
University Hospital, RouenTerminated
-
University Hospital, RouenUniversity Hospital, CaenCompleted